Throughout the 13 years Kent lived with multiple myeloma, he demonstrated strength, perseverance, hope and his wonderful sense of humor.
Kent passed away quietly at home on October 9, 2020 surrounded by his family. Our thoughts are with Debbie, Trevor (Allyson), Bryan (Laura), his beautiful granddaughters and all of Kent’s family and friends.
In lieu of flowers, the Wells family requests that anyone considering a memorial in Kent’s honor to please make a donation in his memory to MMCC.
To donate online, please click the Donate button below; to send a check please send to:
Thank you for your ongoing support of the Multiple Myeloma Charity Classic
Multiple myeloma is a blood cancer that develops in the plasma cells found in bone marrow. Plasma cells are a type of white blood cell critical to maintaining a healthy immune system. In multiple myeloma, plasma cells become malignant and multiply, crowding out healthy cells. As the cancerous myeloma cells proliferate, they can damage bones, cripple the immune system, impair kidney function, and result in chronic anemia.
For more information on Multiple Myeloma, please visit www.themmrf.org.
Since the founding of the Multiple Myeloma Charity Classic in 2009, we have raised over one million dollars for the Multiple Myeloma Research Foundation (MMRF). In that time, research supported by the MMRF has led to:
The Multiple Myeloma Charity Classic is a 501(c)3 non-profit organization. Our mission is to raise awareness and much needed funding for research in the fight against a currently incurable form of cancer, Multiple Myeloma. Our organization hosts an annual Capitol Hill reception, all of which raise funds for the Multiple Myeloma Research Foundation (MMRF).
We chose the MMRF as the beneficiary of our fundraising efforts because it has consistently earned the highest charity rankings by directing nearly 90% of its total budget to research and related programming. The MMRF is one of the leading cancer research organizations worldwide. The unique MMRF Precision Medicine Model is the only end-to-end system in cancer research today and is leading the way to new, innovative treatments and cures.